Viewing Study NCT00820508

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 10:56 AM
Ignite Modification Date: 2026-06-11 @ 11:50 AM
Study NCT ID: NCT00820508
Status: COMPLETED
Last Update Posted: 2011-11-28
First Post: 2009-01-09
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Tolerability of CHR-2845 to Treat Haematological Diseases or Lymphoid Malignancies
Sponsor: Chroma Therapeutics
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematological Disease View
None Lymphoid Malignancies View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Haematological disease View
None Lymphoid malignancy View
None Histone deacetylase inhibitor View
None dose escalation View